<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01310686</url>
  </required_header>
  <id_info>
    <org_study_id>FVF4990s</org_study_id>
    <nct_id>NCT01310686</nct_id>
  </id_info>
  <brief_title>Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy</brief_title>
  <official_title>Genotypic Evaluation of Chronic Exudative Macular Degeneration Despite Monthly Anti-Vascular Endothelial Growth Factor (VEGF) Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>West Coast Retina Medical Group, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Genentech, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>West Coast Retina Medical Group, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To obtain a genotypic analysis of patients with chronic exudative age-related macular
      degeneration noted to have subretinal or intraretinal edema despite continuous monthly
      Anti-VEGF therapy.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Genetic analysis of patients with chronic wet age-related macular degeneration despite continuous anti-VEGF treatment</measure>
    <time_frame>This is a one time only blood draw.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate demographic and clinical characteristics in patients treated with anti-VEGF therapy who fail to respond completely.</measure>
    <time_frame>This is a one time only blood draw and assessment of clinical characteristics.</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Wet AMD</condition>
  <arm_group>
    <arm_group_label>Wet AMD Non-Responders to Anti-VEGF</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with Wet Age-Related Macular Degeneration
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ability to provide written informed consent for participation in this study

          -  Subjects diagnoses of neovascular AMD who are on a monthly anti-VEGF regimen (have had
             &gt;10 or more ranibizumab and/or bevacizumab injections within the last year) and who
             still have intra-retinal or subretinal fluid as confirmed by the Investigator

        Exclusion Criteria:

          -  Subjects with a Pigment Epithelial Detachment Exclusively

          -  Subjects with Serous Pigment Epithelial Detachments

          -  Subjects with history of the following:

        idiopathic polypoidal choroidal vasculopathy

          -  pathologic degenerative myopia

          -  central serous chorioretinopathy

          -  familial drusen

          -  adult onset foveal pattern dystrophy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>West Coast Retina Medical Group, Inc.</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2011</study_first_submitted>
  <study_first_submitted_qc>March 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2011</study_first_posted>
  <last_update_submitted>November 8, 2017</last_update_submitted>
  <last_update_submitted_qc>November 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>West Coast Retina Medical Group, Inc.</investigator_affiliation>
    <investigator_full_name>Arthur D. Fu, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>wet AMD anti-VEGF</keyword>
  <keyword>Genetic analysis of patients with Wet AMD who have not responded fully to anti-VEGF treatments</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitogens</mesh_term>
    <mesh_term>Bevacizumab</mesh_term>
    <mesh_term>Endothelial Growth Factors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

